Davide Campana
St. Orsola Malpighi University Hospital
Bologna, Italy
Bologna, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 139 publications
Refining Prognostic Stratification in Head and Neck Paragangliomas: Insights from a SEER-Based Population Study.
Journal: The Annals of otology, rhinology, and laryngology
Published: August 08, 2026
Lurbinectedin in the therapeutic landscape of SCLC: Key clinical evidence and evolving role in the era of emerging therapies.
Journal: Critical reviews in oncology/hematology
Published: April 25, 2026
Management Strategies and Outcomes for Type 1 Gastric Neuroendocrine Tumors Measuring More Than 1 cm.
Journal: Clinical and translational gastroenterology
Published: March 19, 2026
Phase III meta-analysis of first-line chemo-immunotherapy in ES-SCLC: Survival benefit without detectable class-level differences.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 15, 2026
Primary tumor size as a prognostic factor in duodenal neuroendocrine neoplasms ≤20 mm: a population-based SEER analysis.
Journal: Endocrine oncology (Bristol, England)
Published: November 26, 2025
Real-world presentation and outcomes of gastroenteropancreatic neuroendocrine neoplasms in Italy: findings from the nationwide Itanet prospective database.
Journal: The Lancet regional health. Europe
Published: November 16, 2025
Chronic Hematologic Toxicity After Peptide Receptor Radionuclide Therapy: An Underrecognized Challenge in Neuroendocrine Tumors.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 28, 2025
ARTEMIS: a pilot study comparing AI-based and expert therapeutic decisions in simulated clinical cases of neuroendocrine neoplasms.
Journal: NPJ digital medicine
Published: October 14, 2025
Determinants of incidence trends in pancreatic neuroendocrine neoplasms.
Journal: Journal of neuroendocrinology
Published: October 02, 2025
Baseline neuronal antibodies in patients with small cell lung cancer are not necessarily associated with post-immune checkpoint inhibitors neurotoxicities.
Journal: Frontiers in immunology
Published: August 07, 2025
Updates on Pulmonary Neuroendocrine Carcinoids: Progress and Perspectives.
Journal: Journal of clinical medicine
Published: June 29, 2025
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET).
Journal: ESMO open
Published: June 04, 2025
Last Updated: 09/26/2026